DocGo (DCGO) Competitors $1.26 -0.01 (-0.79%) Closing price 10/8/2025 04:00 PM EasternExtended Trading$1.25 -0.01 (-0.71%) As of 04:05 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock DCGO vs. PSNL, AUNA, TALK, AIRS, AGL, SBC, NAKA, EHAB, TOI, and LFMDShould you be buying DocGo stock or one of its competitors? The main competitors of DocGo include Personalis (PSNL), Auna (AUNA), Talkspace (TALK), AirSculpt Technologies (AIRS), Agilon Health (AGL), SBC Medical Group (SBC), KindlyMD (NAKA), Enhabit (EHAB), Oncology Institute (TOI), and LifeMD (LFMD). These companies are all part of the "healthcare" industry. DocGo vs. Its Competitors Personalis Auna Talkspace AirSculpt Technologies Agilon Health SBC Medical Group KindlyMD Enhabit Oncology Institute LifeMD DocGo (NASDAQ:DCGO) and Personalis (NASDAQ:PSNL) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, profitability, valuation, dividends, earnings, analyst recommendations, institutional ownership and risk. Do analysts prefer DCGO or PSNL? DocGo currently has a consensus target price of $3.24, suggesting a potential upside of 156.94%. Personalis has a consensus target price of $7.42, suggesting a potential downside of 14.55%. Given DocGo's higher possible upside, analysts clearly believe DocGo is more favorable than Personalis.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score DocGo 1 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.17Personalis 1 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.67 Which has preferable earnings and valuation, DCGO or PSNL? DocGo has higher revenue and earnings than Personalis. Personalis is trading at a lower price-to-earnings ratio than DocGo, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDocGo$435.97M0.28$19.99M-$0.19-6.63Personalis$84.61M9.10-$81.28M-$1.28-6.78 Does the media favor DCGO or PSNL? In the previous week, Personalis had 1 more articles in the media than DocGo. MarketBeat recorded 2 mentions for Personalis and 1 mentions for DocGo. Personalis' average media sentiment score of 0.10 beat DocGo's score of 0.00 indicating that Personalis is being referred to more favorably in the news media. Company Overall Sentiment DocGo Neutral Personalis Neutral Which has more volatility and risk, DCGO or PSNL? DocGo has a beta of 0.95, indicating that its stock price is 5% less volatile than the S&P 500. Comparatively, Personalis has a beta of 1.83, indicating that its stock price is 83% more volatile than the S&P 500. Do institutionals & insiders have more ownership in DCGO or PSNL? 56.4% of DocGo shares are owned by institutional investors. Comparatively, 61.9% of Personalis shares are owned by institutional investors. 3.8% of DocGo shares are owned by insiders. Comparatively, 3.8% of Personalis shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Is DCGO or PSNL more profitable? DocGo has a net margin of -4.20% compared to Personalis' net margin of -113.70%. DocGo's return on equity of -3.26% beat Personalis' return on equity.Company Net Margins Return on Equity Return on Assets DocGo-4.20% -3.26% -2.24% Personalis -113.70%-47.57%-35.05% SummaryDocGo beats Personalis on 8 of the 15 factors compared between the two stocks. Get DocGo News Delivered to You Automatically Sign up to receive the latest news and ratings for DCGO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DCGO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DCGO vs. The Competition Export to ExcelMetricDocGoMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$124.22M$8.17B$6.09B$10.54BDividend YieldN/A2.83%5.69%4.71%P/E Ratio-6.6374.0085.3527.60Price / Sales0.2833.35539.78202.41Price / Cash3.0022.8037.9261.55Price / Book0.416.9713.016.76Net Income$19.99M$247.60M$3.30B$275.88M7 Day Performance-1.56%1.11%4.34%2.81%1 Month Performance-20.25%0.75%9.49%9.24%1 Year Performance-60.63%13.32%84.83%35.42% DocGo Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DCGODocGo1.4126 of 5 stars$1.26-0.8%$3.24+156.9%-59.9%$124.22M$435.97M-6.634,407News CoverageAnalyst ForecastPSNLPersonalis3.0922 of 5 stars$6.35+5.1%$7.42+16.8%+66.6%$535.61M$84.61M-4.96400Analyst ForecastAUNAAuna4.0854 of 5 stars$6.66flat$10.70+60.7%-2.7%$492.93M$1.17B7.5714,842Positive NewsTALKTalkspace3.8352 of 5 stars$2.76-0.7%$4.50+63.0%+25.3%$465.56M$187.59M138.07500News CoverageAnalyst DowngradeAIRSAirSculpt Technologies0.9656 of 5 stars$7.54+1.6%$3.75-50.3%+67.3%$463.28M$165.11M-30.16240Positive NewsAGLAgilon Health2.2126 of 5 stars$1.11+1.4%$3.07+178.0%-65.9%$451.72M$6.06B-1.441,076News CoverageAnalyst ForecastSBCSBC Medical Group3.3176 of 5 stars$4.26-0.2%N/A-47.4%$443.57M$205.42M13.31N/APositive NewsNAKAKindlyMD2.1498 of 5 stars$1.17+1.7%$8.00+583.8%N/A$434.85M$2.24M-1.36N/AAnalyst ForecastGap DownEHABEnhabit2.346 of 5 stars$8.04-0.9%$8.67+7.9%+12.6%$411.10M$1.03B-3.0110,700News CoveragePositive NewsAnalyst ForecastTOIOncology Institute2.4052 of 5 stars$3.46-2.3%$7.00+102.3%+1,168.4%$331.01M$424.38M-5.09660Positive NewsAnalyst ForecastLFMDLifeMD3.5155 of 5 stars$6.44+0.2%$13.17+104.5%+42.2%$304.89M$212.45M-30.67230Analyst Forecast Related Companies and Tools Related Companies PSNL Alternatives AUNA Alternatives TALK Alternatives AIRS Alternatives AGL Alternatives SBC Alternatives NAKA Alternatives EHAB Alternatives TOI Alternatives LFMD Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DCGO) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DocGo Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DocGo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
